Drug Product Selection, Compounding, and Storage/Handling Standards
This domain covers the pharmacist's product-level judgment: substituting a therapeutically equivalent generic, compounding preparations, and maintaining drug integrity. For drug product selection, Florida requires that the substituted product be therapeutically equivalent and that the patient or prescriber be informed as the statute requires; the prescription record must show the manufacturer and the dispensed product. Traps include substituting a product that is not rated equivalent, and failing to document the substitution. Compounding questions test the distinction between sterile and non-sterile compounding, the need for appropriate equipment and beyond-use dating, and the prohibition on copying a commercially available product in certain contexts. Storage questions address temperature ranges (controlled room temperature, refrigeration, freezing), protection from light, and segregation of expired or recalled stock. Watch for questions about repackaging and beyond-use dates after a container is opened. Rule of thumb: if you cannot verify therapeutic equivalence from an authoritative rating, do not substitute. Worked example: a prescriber writes for a brand drug and the patient asks for a generic. The pharmacist may substitute only if the generic is rated therapeutically equivalent, must record the manufacturer and product dispensed, and must follow the notification requirements.